Heat Biologics launched program to develop vaccine to protect against COVID-19 coronavirus
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
On Mar. 2, 2020,Gilead Sciences announced it had acquired Forty Seven Inc. for $95.50 per share in cash…
On Mar. 2, 2020, Ophirex announced that it had received a $2.5 million award from the Wellcome Trustï¾’s…
On Feb. 28, 2020, the FDA approved an application for the first generic of Daraprim (pyrimethamine) tablets for…
On Feb. 28, 2020, Altimmune announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology…
On Feb. 24, 2020, Clover Biopharmaceuticals announced a research collaboration with GSK for its protein-based coronavirus vaccine candidate…
On Feb. 24, 2020, Innovation Pharmaannounced the Company submitted a Material Transfer Agreement (MTA) with a leading U.S.-based…
On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A…
On Feb. 19, 2020, NIAID scientists working with investigators from the University of Texas at Austin identified the…
On Feb. 18, 2020, Innovation Pharma announced the Company was exploring its lead defensin mimetic drug candidate, Brilacidin,…
On Feb. 12, 2020, leading health experts from around the world met at the World Health Organization’s (WHO)…
On Feb. 12, 2020, Chembio Diagnostics announced a $1.5 million purchase order from UNICEF for multiplex Zika tests…
On Feb. 7, 2020, two University of Nebraska Medical Center faculty members are among a group of researchers…
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
On Feb. 3, 2020, the CDC released the 2020 recommended immunization schedules for children and adolescents, as well…
On Jan. 31, 2020, Mammoth Biosciences announced the company had received a contract from the National Institutes of…
On Jan. 23, 2020, the new cluster of viral pneumonia cases originating in Wuhan, China, marked the third…
On Jan. 23, 2020, the Vanderbilt Vaccine Research Program (VVRP) received a grant from the National Institutes of…
On Jan. 22, 2020, Johns Hopkins engineering professor Dr. Lauren Gardner created the COVID dashboard used around the…
On Jan. 20, 2020, deCODE genetics reported a genome-wide association meta-analysis of 69,189 cases and 702,199 controls from…
On Jan. 17, 2020, the Non-profit drug developer TB Alliance granted Shenyang Hongqi Pharmaceuticals , a subsidiary of…
On Jan 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency…
On Jan. 13, 2020, Vanderbilt University Medical Center researcher Ela Knapik, MD and her colleagues announced they had…
On Jan. 13, 2020, a team of scientists from the University of Vermont and Tufts University annouced they…
On Jan. 10, 2020, Mayo Clinic researchers reported that they had discovered a molecular switch for repairing central…
On Dec. 24, 2019, the National Institute of Allergy and Infectious Diseases (NIAID) established the Infectious Diseases Clinical…
On Dec. 20, 2019, Dr. Pedro Rosa-Neto announced the discovery that the protein APOE ?4 plays a central…
On Dec. 16, 2019, researchers at the National Eye Institute launched a clinical trial to test the safety…
On Dec. 4. 2019, Nanomix announced that the company had received CE Mark for its S1 Assay for…